Thanks to this Postgraduate certificate you will be able to incorporate the latest advances in the approach to infectious pathology in your daily pharmacological practice"

Infectious diseases remain the leading cause of mortality and disability (loss of productive life years) in the world. In 2016, of the total 56.4 million deaths worldwide, 33% were due to infectious diseases, 30% to cardiovascular diseases and 10% to cancer. The fight against disease will have two simultaneous fronts: infectious diseases and chronic non-communicable diseases. 

Among the 17.3 million people who died from infections in 2016, the most frequent causes of death were lower respiratory infections (3.7 million), malaria (2.2 million), tuberculosis (1.3 million), diarrhea (1.4 million), and HIV/AIDS infection (1.1 million). The most important factors to take into consideration in relation to infectious diseases are demographics and human behavior, technological and industrial development, economic development and variations in land use, intercontinental travelling and commerce, climate change, microbiotic adaptation and finally the disappearance or reduction of efficient public health measures.

These factors, interacting with each other, have conditioned that we should not consider any part of the planet reasonably isolated from the rest, nor impossible the appearance, reappearance or dissemination of imported or apparently eradicated infectious diseases in our environment.

Seize the moment and gain up-to-date knowledge on the management of coronavirus infections"

This Postgraduate certificate in Infection Control in Immunocompromised Patients contains the most complete and up-to-date program on the market. The most important features of the program include: 

• Development of clinical cases presented by experts in Infections Control in the Immunocompromised Patients
• The graphic, schematic, and practical contents with which they are created provide scientific and practical information on the disciplines that are essential for professional practice
• New developments on Infection Control in Immunocompromised Patients
• Practical exercises where self-assessment can be used to improve learning
• An algorithm-based interactive learning system for decision-making in the clinical situations presented throughout the course
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

TECH offers you the most up-to-date program in Infection Control in Immunocompromised Patients from the pharmaceutical perspective"

Its faculty is made up of prestigious and renowned professionals, with a long history in health care, teaching and research, who have worked in many countries on several continents, developing a professional and teaching experience that they deliver in an extraordinary way in this program.

The methodological design of this program, developed by a multidisciplinary team of e-learning experts, integrates the latest advances in educational technology for the creation of numerous multimedia educational tools that allow the professional, based primarily on the problem-solving method, to face the solution of real problems in their daily clinical practice, which will allow them to progress in the acquisition of knowledge and the development of skills that will impact their future professional work.

It should be noted in this program that all of the contents generated, as well as the videos, self-evaluations, clinical cases and exams have been thoroughly reviewed, updated, and integrated by the teachers and the team of experts that make up the working group, to facilitate the learning process with a step-by-step approach in order to achieve the teaching program objectives.

This program, recently updated due to the global pandemic situation, is the best in the educational landscape for viral infections"

Do not miss the opportunity to learn about the advances in the treatment of infections to incorporate them into your daily pharmaceutical practice"

The teaching program has been created by a group of professors and professionals in pharmacy and medicine, from various medical specialties, with extensive research and teaching experience in several countries in Africa, Central and South America, interested in integrating the latest and most current scientific knowledge of clinical infectology and antimicrobial therapeutics to ensure training and professional development to improve the daily clinical practice of professionals who care for patients or populations with infectious diseases.

This Postgraduate certificate in Infection Control in Immunocompromised Patients contains the most complete and up-to-date program on the market”

Module 1. The Immune System and Infections in Immunosuppressed Patients

1.1.  Structure and Development of the Immune System

1.1.1.  Composition and Development of the Immune System
1.1.2.  Immune System Organs
1.1.3.  Immune System Cells
1.1.4.  Chemical Mediators in the Immune System

1.2.   The Immune Response to Viral and Bacterial Infections

1.2.1.  Main Cells Implicated in the Immune Response to Viruses and Bacteria
1.2.2. Main Chemical Mediators

1.3.  The Immune Response to Mycotic and Parasitic Infections

1.3.1.  Immune Response Against Filamentous and Yeast Fungi
1.3.2.  Immune Response Against Protozoas
1.3.3.  Immune Response Against Helminths

1.4.   Most Common Clinical Manifestations of Immunosuppression

1.4.1.  Types of Immunosuppression
1.4.2.  Clinical Manifestations According to the Infectious Agent
1.4.3.  Frequent Infections According to the Type of Immunosuppression
1.4.4.  Common Infections in Immunosuppressed Patients According to the Organ System Affected

1.5.  The Fever Syndrome in Neutropenic Patients

1.5.1.  Most Common Clinical Manifestations
1.5.2.  Most Diagnosed Infectious Agents
1.5.3.  Most-Used Complementary Studies in the Integral Evaluation of a Neutropenic Fever Patient
1.5.4.  Therapeutic Recommendations

1.6.  Management of an Immunosuppressed Patient with Sepsis

1.6.1.  Evaluation of Diagnosis, Prognosis and Treatment According to the Latest International Recommendations Endorsed by Scientific Evidence

1.7.  Immunomodulatory and Immunosuppressive Therapy

1.7.1.  Immunomodulators and Their Clinical Use
1.7.2.  Immunosuppressors and Their Relation to Sepsis

A unique, key, and decisive experience to boost your professional development”